Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 51 | 14.07.08 | |
Director of Finance/CFO | 51 | 02.03.22 | |
Patrick Sartore
PSD | President | 49 | 01.01.06 |
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.05.19 |
Director/Board Member | 67 | 14.05.14 | |
Shrinal Inamdar
IRC | Investor Relations Contact | - | - |
Marie Iskra
LAW | General Counsel | 48 | 01.09.19 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gary Bridger
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.05.19 |
Director/Board Member | 67 | 14.05.14 | |
Alek Krstajic
CHM | Chairman | 60 | 01.09.20 |
Neil Klompas
BRD | Director/Board Member | 52 | 01.05.19 |
Eugene Siklos
BRD | Director/Board Member | 60 | 01.09.20 |
Director/Board Member | 63 | 01.05.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 3 249 534 | 1 258 903 ( 38,74 %) | 0 | 38,74 % |
Unternehmenskontakt
Liminal BioSciences, Inc.
440, boulevard Armand-Frappier Suite 300
H7V 4B4, Laval
+450 781 0115
http://www.liminalbiosciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+25,69 % | 47,86 Mrd. | |
+46,90 % | 41,42 Mrd. | |
-3,46 % | 40,66 Mrd. | |
-6,20 % | 28,92 Mrd. | |
+9,17 % | 25,55 Mrd. | |
-20,42 % | 19,27 Mrd. | |
+0,17 % | 12,15 Mrd. | |
+28,07 % | 12,14 Mrd. | |
-1,24 % | 11,99 Mrd. |